01 · A living model of the cancer
Twin capabilities
Four capabilities, built on 21 layers.
01
Understand
Bring molecular findings and relevant clinical context into a structured view.
Characterise molecular alterations and relevant tumour biology; place results in the context of diagnosis, stage, prior therapies and available patient information.
Informs report sections
- 01 Executive molecular summary
- 02 Molecular findings
Layers that inform “Understand”
02
Connect
Relate molecular, imaging, immune and patient information where available.
Integrate molecular information with imaging, immune landscape, patient factors, treatment exposure and evidence sources — only where these inputs are available.
Informs report sections
- 02 Molecular findings
- 05 Longitudinal view
Layers that inform “Connect”
03
Explore
Review treatment-relevant evidence, resistance-related findings and potential trial matches.
Organise actionable alterations, targetability, treatment-related evidence, possible resistance mechanisms, toxicity and tolerability considerations, costs and trial information for review.
Informs report sections
- 03 Treatment options
- 04 Clinical-trial matches
Layers that inform “Explore”
- 6AccessMatchActionable alterations and targetability
- 8ResistMapResistance mechanisms and bypass routes
- 14Treatment Response PredictionLikelihood of response and resistance
- 16TrialGraphClinical trial matching and prioritisation
- 17ToxCastTherapy toxicity risk and tolerability
- 18CostPathTreatment pathways and cost considerations
04
Follow
Revisit the picture as new findings and evidence become available.
Support a longitudinal view, evidence updates and a record of decisions or outcomes where implemented.
Informs report sections
- 05 Longitudinal view